Semi-Annual Consolidated Statement Of Cash Flows

Renascience Inc. - Filing #7296926

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-72,045,000 JPY
-94,343,000 JPY
Depreciation
JPY
911,000 JPY
Decrease (increase) in trade receivables
4,400,000 JPY
JPY
Other, net
JPY
54,000 JPY
Subtotal
-130,324,000 JPY
-82,324,000 JPY
Income taxes paid
-1,979,000 JPY
-1,955,000 JPY
Net cash provided by (used in) operating activities
-132,137,000 JPY
-84,271,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
2,250,000 JPY
JPY
Cash flows from financing activities
Proceeds from long-term borrowings
9,476,000 JPY
46,500,000 JPY
Net cash provided by (used in) financing activities
9,476,000 JPY
46,500,000 JPY
Net increase (decrease) in cash and cash equivalents
-120,411,000 JPY
-37,771,000 JPY
Cash and cash equivalents
1,525,782,000 JPY
1,646,193,000 JPY
1,794,008,000 JPY
1,831,780,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.